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Abstract 
Human genomic DNA analysis reveals the existence of polymorphisms at the cell molecular adhesion regulator (CMAR) locus. In 
order to choose between the two possible open frames deduced from the variant sequence, we have sequenced both the human 5' 
non-coding region and the mouse CMAR variant DNA. We found that both mRNA species coexist in human cells. 
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In a colon cancer cell line, Pullman and Bodmer identi- 
fied a cDNA which encodes a potential adhesion regulator 
named cell molecular adhesion regulator (CMAR) [I]. 
CMAR is suspected to be a tumor suppressor gene since it 
has been located in the peritelomeric region of the long 
arm of chromosome 16, a region often affected in breast 
and prostatic tumors [2]. Analysis of human genomic DNA 
revealed the existence of polymorphisms at the CMAR 
locus [2,3]. Heterozygosity for a 4-bp insertion (CACA) at 
position 95 of the nucleotide sequence was reported in 
about 40% of normal caucasoid individuals [3]. Two possi- 
ble open frames can be deduced from the cDNA sequence 
(Fig. 1). The first alignment conserves the N-terminus of 
the original CMAR sequence, while the second one starts 
at position 83 and leaves the C-terminus unmodified. 
Durbin et al. favor the latter hypothesis [3] since the 
C-terminus encompasses a putative tyrosine phosphoryla- 
tion site which has been suspected to be important for the 
adhesive phenotype [I]. A possible myristoylation site was 
also identified at the N-terminus and may play a role in the 
membrane localization of CMAR. Thus both open frames 
keep a potentially important site. It is important o define 
which protein is encoded by the CMAR variant. In order to 
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i EMBL Data Bank accession numbers are Z35498 and Z50147 for the 
human and the mouse CMAR variant sequences respectively. 
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choose between the two possibilities, we have sequenced 
the human 5' non-coding region and the mouse CMAR 
variant DNA. We took the advantage of CMAR polymor- 
phisms in Reh cells (ATCC CRL 8286) to determine 
whether both mRNA species coexist. 
Analysis of  the 5' non-coding region upstream ATG and 
sequence homology. Since translation by ribosomes de- 
pends on the 5' non-coding sequence, we have cloned and 
sequenced the corresponding genomic CMAR variant se- 
quence. The sequence CCUC GGA AUG C which en- 
compasses the initiation codon of the original CMAR is 
fully conserved in the variant sequence. The consensus 
sequence (CGCC A /GCC AUG G) was defined to be 
optimal for eucaryotic ribosomes [4]. Within this sequence 
positions -3  and +4 seem crucial [5]. Both CMAR 
variant putative initiation codons are in a moderately good 
context. AUG 1 fits with the consensus equence at posi- 
tion -3  but not at position +4,  whereas the opposite 
holds for the second initiation sequence (CUCA UCA 
AUG G) at position 83. However, the context alone does 
not determine the start site for translation since among 
natural eukaryotic mRNA, only 5% have the ideal CCAC- 
CATGG sequence [5]. Durbin et al. [1] have established 
that the original CMAR sequence starts at AUG 1. Since 
AUG 1 is in the same context in both sequences and taking 
into account he absence of more-upstream potential AUG 
codon, we expect that ribosomes will initiate at the first 
AUG. 
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Fig. 1. Sequences of putative CMAR proteins. The two open frames are 
indicated below the cDNA variant sequence. Residues in bold are also 
present in the original CMAR sequence. The putative N-terminus myris- 
toylation site and the C-terminus possible phosphorylated sites are under- 
lined as well as the 4-bp insertion. Protein 1 presents 50% identity with 
CMAR and fully conserves the N-terminus of the original protein. 
Translation from bp 83 leads to protein 2. Protein 2 is 91% identical to 
CMAR and keeps the C-terminus unmodified. 
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Fig. 2. Analysis of amplified DNA. DNA were amplified with primer set 
A: (5'-ACGACCGCCCCAGTTCC) and (5'-TAAAGTATCTCAACAA), 
then in a second PCR reaction with primer set (5'-AGTCTAAGGG- 
GATCGG) and (5'-AGTCCTCCGGAGCCC AG). Amplification prod- 
ucts were denatured in a 80% formamide solution by heating at 95°C for 
5 min, then placed on ice and quickly loaded onto 8% polyacrylamide 
slab gel. Amplification products of Reh cDNA were loaded in lane 4 
while the control in which the reverse transcriptase was omitted was 
loaded in lane 5. The amplification product of the original CMAR cDNA 
was loaded in lane 2 while the 4-bp variant amplification product was in 
lane 1. Both CMAR cDNA species were mixed and loaded in lane 3. The 
l Kb ladder (Gibco-BRL, USA) was in lane 6. The electrophoresis was 
performed in 0.5 × TBE at 300V for 5 h at the constant temperature of
15°C and DNA was stained by BET. 
Analysis of the mouse homologous sequence reveals 
three modifications among the whole DNA sequence (Ta- 
ble 1). If translation starts at AUG 1, only one modifica- 
tion lies within the coding region and is a silent mutation. 
Conversely if translation starts at AUG 83, the three 
modifications are included within the coding sequence and 
the deduced protein is different. The charge of the protein 
is modified since an aspartic acid is replaced by an alanine. 
All these data strongly favour the AUG 1 translation 
Table l 
Comparison between human and mouse CMAR variant DNA 
Position ~ Variations b Translation c 
Phase 1 Phase 2 
153 A ~ C GGA --~ GGC GAC --* GCC 
Gly ~ Gly Asp ~ Ala 
191 G ~ A Non-coding region GCA ~ ACA 
Ala ~ Thr 
196 C --* T Non-coding region TGC ~ TGT 
Cys ~ Cys 
Genomic DNA from mus musculus lymphoblastic EL 4 cells (ATCC TIB 
39) were amplified with primer set A (as defined in Fig. 2). Resulting 
DNA were subcloned into p-bluescript SK +/ -  and plasmid sequences 
were analyzed using the sequenase version 2.0 DNA polymerase 
(Amersham), 
Position of the modified nucleotide within the human CMAR cDNA 
sequence. 
b Nucleotide changes from human to mouse. 
c Translation phase 1 refers to AUG 1 start. 
Translation phase 2 refers to AUG 83 start. 
Modifications from human to mouse are listed, amino acids are indicated 
below the modified codon. 
start for the CMAR variant. Durbin et al. [3] reported that 
transfection of either the full original CMAR cDNA or the 
variant cDNA from position 83 to 396 were able to 
enhance adhesion of cells to collagen type 1. This clearly 
indicates that the CMAR functional domain lies within 
amino acids 32 and 82 but is not evidence of the function- 
ality of the variant protein. Transfected cells may express 
either the actual CMAR variant protein, or possibly a 
mutant of the original CMAR protein which has kept the 
functional site. Finally, the functionality of the variant 
protein is still unknown. 
Coexistence of the two CMAR mRNA species. Total 
RNA from Reh cells was reverse transcribed in cDNA and 
a 261-pb DNA fragment spanning the complete CMAR 
sequence was generated in the first PCR round. Then, a 
fraction of the resulting DNA was used as a template for 
the ensuing amplification with inner primer sets. Two-stage 
PCR allows the cold detection of CMAR cDNA and 
increases the specificity of the reaction. We performed 
single-strand conformational polymorphism analysis of the 
amplified products. The 4-bp insertion CMAR cDNA mi- 
grates more slowly than CMAR cDNA (Fig. 2, lanes 1, 2, 
3). Fig. 2 reveals the presence of two mRNA species in 
Reh cells (lane 4 versus lane 5 as control). The lower band 
comigrates with the CMAR cDNA (lanes 2 and 3), while 
the upper one comigrates with the CMAR variant cDNA 
(lanes 1 and 3). The ratio of both RNA species was 
estimated by densitometric scanning to be approximately 
1:1. 
In conclusion, two CMAR RNA species coexist in 
human cells leading to the potential existence of two 
CMAR proteins in the same cells. From sequence analysis, 
8 A. Molla et al./Biochimica et Biophysica Acta 1315 (1996) 6-8 
a translation start at AUG 1 is most likely. In this case the 
two proteins would be related by the N-terminus and the 
variant form would have lost the putative tyrosine 
phosphorylation site. 
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